The rise of GLP-1 weight-loss drugs is starting to reshape how and how much people eat. For food and drink manufacturers, that raises difficult questions about future demand, portion sizes, product formulation and the role of food itself.

This keynote explores what GLP 1 could mean in practice for new product development.